Windsor Wealth Management’s Celgene Corp CELG Stock Holding History

Windsor Wealth Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,338	Closed	-$326K	–	189
2019 Q3	$326K	Sell	3,338 -1,768	-35%	-$168K	0.14%	139
2019 Q2	$477K	Buy	5,106 +1,491	+41%	+$142K	0.21%	117
2019 Q1	$341K	Buy	3,615 +37	+1%	+$3.24K	0.19%	116
2018 Q4	$229K	Sell	3,578 -400	-10%	-$29.5K	0.16%	121
2018 Q3	$356K	Sell	3,978 -414	-9%	-$36.6K	0.23%	100
2018 Q2	$349K	Sell	4,392 -222	-5%	-$18.4K	0.27%	94
2018 Q1	$412K	Hold	4,614	–	–	0.35%	83
2017 Q4	$482K	Buy	+4,614	New	+$521K	0.41%	61

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Windsor Wealth Management's CELG Position: Q4 2019 in Review

Windsor Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,338 shares — an estimated $326K sold.

Windsor Wealth Management first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $482K in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Windsor Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Windsor Wealth Management sold 3,338 Celgene Corp shares in Q4 2019, an estimated $326K.
Windsor Wealth Management first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
Windsor Wealth Management's Celgene Corp position peaked at $482K in Q4 2017.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Windsor Wealth Management's 13F filing for Q4 2019, filed 7 Jan 2020.